Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 02, 2023 Filed Feb 3, 2023 21:56 UTC |
Huber Martin H. Jr.Director
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000946 · primarydocument.xml · nonDerivative · entry 1 Huber Martin H. Jr. · CIK 0001653276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:55 UTC |
Meury WilliamDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000945 · primarydocument.xml · nonDerivative · entry 1 Meury William · CIK 0001536778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:59 UTC |
Ordentlich PeterChief Scientific Officer
|
SaleCommon Stock | 69 | $28.43 | $1,961.54 |
DisclosureSEC source: 0001562180-23-000950 · primarydocument.xml · nonDerivative · entry 2 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 21:59 UTC |
Ordentlich PeterChief Scientific Officer
|
OtherCommon Stock | 69 | $17.32 | $1,195.08 |
DisclosureSEC source: 0001562180-23-000950 · primarydocument.xml · nonDerivative · entry 1 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69 F1 · kind: The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 69 shares by the Reporting Person on 01/31/2023 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 5,000 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · derivative · entry 9 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · derivative · entry 8 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
SaleCommon Stock | 5,000 | $27.00 | $135,000.00 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · nonDerivative · entry 6 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of no options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
Exercise / conversionCommon Stock | 5,000 | $13.58 | $67,900.00 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · nonDerivative · entry 5 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
SaleCommon Stock | 10,000 | $27.00 | $270,000.00 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · nonDerivative · entry 4 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of no options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
Exercise / conversionCommon Stock | 10,000 | $13.58 | $135,800.00 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · nonDerivative · entry 3 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 24,000 | $0.00 Strike: $9.47 | $0.00 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · derivative · entry 7 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2030-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
SaleCommon Stock | 24,000 | $26.74 | $641,781.60 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · nonDerivative · entry 2 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of no options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $26.50 to $26.93. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 16:44 UTC |
Legault PierreDirector
|
Exercise / conversionCommon Stock | 24,000 | $9.47 | $227,280.00 |
DisclosureSEC source: 0001562180-23-000413 · primarydocument.xml · nonDerivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 21:41 UTC |
Sabus Steve MChief Commercial Officer
|
GrantStock Options (Right to buy) · Derivative | 220,000 | $25.44 Strike: $25.44 | $5,596,800.00 |
DisclosureSEC source: 0001562180-22-008056 · primarydocument.xml · derivative · entry 1 Sabus Steve M · CIK 0001930884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2032-12-05 F1 · derivative.exercise_date: Twenty five percent (25%) of the total number of shares underlying the option shall vest on December 5, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 17,200 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · derivative · entry 9 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,200 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
SaleCommon Stock | 17,200 | $25.05 | $430,935.68 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · nonDerivative · entry 6 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 255,925 options to purchase shares of common stock that are vested and immediately exercisable and a total of 122,916 options to purchase shares of common stock that have not yet vested. F3 · price: The sale prices ranged from $25.00 to $25.19. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionCommon Stock | 17,200 | $6.38 | $109,736.00 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · nonDerivative · entry 5 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 3,772 | $0.00 Strike: $6.35 | $0.00 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · derivative · entry 8 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,772 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 4,028 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · derivative · entry 7 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,028 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
SaleCommon Stock | 4,028 | $25.01 | $100,745.92 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · nonDerivative · entry 4 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 255,925 options to purchase shares of common stock that are vested and immediately exercisable and a total of 122,916 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.00 to $25.03. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionCommon Stock | 4,028 | $6.38 | $25,698.64 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · nonDerivative · entry 3 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
SaleCommon Stock | 3,772 | $25.01 | $94,343.00 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · nonDerivative · entry 2 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 255,925 options to purchase shares of common stock that are vested and immediately exercisable and a total of 122,916 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.00 to $25.03. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 22:01 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionCommon Stock | 3,772 | $6.35 | $23,952.20 |
DisclosureSEC source: 0001562180-22-008017 · primarydocument.xml · nonDerivative · entry 1 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Katkin KeithDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 20,782 | $0.00 Strike: $7.88 | $0.00 |
DisclosureSEC source: 0001562180-22-007125 · primarydocument.xml · derivative · entry 6 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,782 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Katkin KeithDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 9,117 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001562180-22-007125 · primarydocument.xml · derivative · entry 5 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,117 shares Expires 2028-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Katkin KeithDirector
|
SaleCommon Stock | 9,117 | $25.90 | $236,138.51 |
DisclosureSEC source: 0001562180-22-007125 · primarydocument.xml · nonDerivative · entry 4 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 73,000 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.0000 to $26.4600. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Katkin KeithDirector
|
Exercise / conversionCommon Stock | 9,117 | $8.93 | $81,414.81 |
DisclosureSEC source: 0001562180-22-007125 · primarydocument.xml · nonDerivative · entry 3 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Katkin KeithDirector
|
SaleCommon Stock | 20,782 | $25.90 | $538,272.50 |
DisclosureSEC source: 0001562180-22-007125 · primarydocument.xml · nonDerivative · entry 2 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 73,000 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.0000 to $26.4600. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Katkin KeithDirector
|
Exercise / conversionCommon Stock | 20,782 | $7.88 | $163,762.16 |
DisclosureSEC source: 0001562180-22-007125 · primarydocument.xml · nonDerivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 16,231 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-22-007124 · primarydocument.xml · derivative · entry 3 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,231 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
SaleCommon Stock | 16,231 | $25.29 | $410,507.96 |
DisclosureSEC source: 0001562180-22-007124 · primarydocument.xml · nonDerivative · entry 2 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 674,528 options to purchase shares of common stock that are vested and immediately exercisable and a total of 485,001 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.1500 to $25.4350. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:05 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 16,231 | $8.77 | $142,345.87 |
DisclosureSEC source: 0001562180-22-007124 · primarydocument.xml · nonDerivative · entry 1 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 137 | $0.00 Strike: $7.88 | $0.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · derivative · entry 18 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 137 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 223 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · derivative · entry 17 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 223 shares Expires 2028-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
SaleCommon Stock | 223 | $25.00 | $5,575.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 12 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 102,899 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F3 · price: The sale price was $25.00. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionCommon Stock | 223 | $8.93 | $1,991.39 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 11 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
SaleCommon Stock | 137 | $25.00 | $3,425.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 10 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 102,899 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F3 · price: The sale price was $25.00. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionCommon Stock | 137 | $7.88 | $1,079.56 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 9 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 1,280 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · derivative · entry 9 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,280 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
SaleCommon Stock | 1,280 | $25.02 | $32,026.37 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · nonDerivative · entry 6 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 690,759 options to purchase shares of common stock that are vested and immediately exercisable and a total of 485,001 options to purchase shares of common stock that have not yet vested. F3 · price: The sale prices ranged from $25.00 to $25.03. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,280 | $8.77 | $11,225.60 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · nonDerivative · entry 5 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 167 | $0.00 Strike: $7.88 | $0.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · derivative · entry 16 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 167 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 13 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · derivative · entry 15 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13 shares Expires 2028-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
SaleCommon Stock | 13 | $25.00 | $325.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 8 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 102,899 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F3 · price: The sale price was $25.00. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionCommon Stock | 13 | $8.93 | $116.09 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 7 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
SaleCommon Stock | 167 | $25.00 | $4,175.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 6 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 102,899 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F3 · price: The sale price was $25.00. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionCommon Stock | 167 | $7.88 | $1,315.96 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 5 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 2,883 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · derivative · entry 8 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,883 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
SaleCommon Stock | 2,883 | $25.01 | $72,106.71 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · nonDerivative · entry 4 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 690,759 options to purchase shares of common stock that are vested and immediately exercisable and a total of 485,001 options to purchase shares of common stock that have not yet vested. F3 · price: The sale prices ranged from $25.00 to $25.03. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,883 | $8.77 | $25,283.91 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · nonDerivative · entry 3 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.